What We're Reading: Panel on Sickle Cell Gene Therapy; Infant Mortality Rises; Campaign Against Burnout
A panel of experts agreed that exa-cel, a sickle cell disease gene therapy, was safe enough for clinical use, setting the stage for a potential FDA approval; the United States saw an increase in infant mortality rates for the first time in more than 2 decades; the new antiburnout campaign from the CDC asks leaders to better support health care workers.
Source: ajmc.com